Q32 Bio, Inc. (QTTB)
16.34
+0.37
(+2.32%)
USD |
NASDAQ |
Aug 24, 16:00
16.34
0.00 (0.00%)
After-Hours: 20:00
Q32 Bio Total Assets (Quarterly) : 115.87M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 115.87M |
| March 31, 2026 | 63.68M |
| December 31, 2025 | 61.78M |
| September 30, 2025 | 57.78M |
| June 30, 2025 | 66.12M |
| March 31, 2025 | 79.07M |
| December 31, 2024 | 92.33M |
| September 30, 2024 | 104.54M |
| June 30, 2024 | 124.21M |
| March 31, 2024 | 152.33M |
| December 31, 2023 | 47.06M |
| September 30, 2023 | 140.06M |
| June 30, 2023 | 169.34M |
| March 31, 2023 | 197.88M |
| December 31, 2022 | 228.47M |
| September 30, 2022 | 262.65M |
| June 30, 2022 | 284.61M |
| March 31, 2022 | 310.96M |
| Date | Value |
|---|---|
| December 31, 2021 | 211.72M |
| September 30, 2021 | 230.82M |
| June 30, 2021 | 258.92M |
| March 31, 2021 | 234.70M |
| December 31, 2020 | 263.74M |
| September 30, 2020 | 228.36M |
| June 30, 2020 | 258.24M |
| March 31, 2020 | 288.79M |
| December 31, 2019 | 310.57M |
| September 30, 2019 | 316.76M |
| June 30, 2019 | 341.16M |
| March 31, 2019 | 233.03M |
| December 31, 2018 | 259.09M |
| September 30, 2018 | 268.40M |
| June 30, 2018 | 270.31M |
| March 31, 2018 | 129.08M |
| December 31, 2017 | 137.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Rallybio Corp. | 98.06M |
| Beam Therapeutics, Inc. | 1.386B |
| C4 Therapeutics, Inc. | 359.40M |
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.962M |
| Shareholders Equity (Quarterly) | 105.90M |
| Debt to Equity Ratio | 0.05 |
| Current Ratio | 20.28 |
| Net Debt Paydown Yield | 0.89% |